摘要:
The present invention relates to new pyranoside derivatives of general formula I, processes for preparing them as well as their use as medicaments:
摘要:
The present invention relates to new benzamidine derivatives, processes for preparing them and their use in pharmaceutical compositions. The new benzamidine derivatives correspond to general formula 1
摘要:
The invention relates to new phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions. The phenylamidines according to the invention correspond to the general formula I ##STR1##
摘要:
The present invention relates to new phenylamine derivatives, processes for preparing them and their use as pharmaceutical compositions. The phenylamines according to the invention correspond to the general formula I
摘要:
Medicaments and pharmaceutical kits comprising an LTB4 antagonist of formula (I) a tautomer thereof or a pharmaceutically acceptable salt thereof, and methods of treating or preventing cystic fibrosis, diseases caused by increased expression of mucin genes in the bronchial or gastrointestinal epithelium, or hyperplasia of goblet cells induced by toxins of products of pathogenic bacteria in a patient in need of such treatment, the method comprising administering to the patient a therapeutically effective amount of an LTB4 antagonist of formula (I).
摘要:
Compounds of formula ##STR1## and their therapeutic use, inter alia, as LTB.sub.4 -antagonists. Exemplary compounds are: (Methoxycarbonyl-imino-{4'-�2-(2-propylphenoxy)-ethoxy!-biphenyl-4-yl}-methyl)-amine; (Benzyloxycarbonyl-imino-{4'-�2-(2-propylphenoxy)-ethoxy!-biphenyl-4-yl}-methyl-amine; �Hydroxy-imino-(4-{3-�4-(1-methyl-1-phenylethyl)-phenoxymethyl!-benzoyloxy}phenyl)-methyl!-amine; �Ethoxycarbonyl-imino-(4-{3-�4-(1-methyl-1-phenylethyl)-phenoxymethyl!-benzoyloxy}phenyl)-methyl!-amine; and, �3'-Pyridylcarbonyl-imino-(4-{3-�4-(1-methyl-1-phenylethyl)-phenoxymethyl!-benzyloxy}phenyl)-methyl!-amine.
摘要:
Compounds of the formula which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.
摘要:
Pyranoside derivatives of the formula I wherein 1, m and n independently of one another denote an integer chosen from 0, 1, 2, 3 and 4 and 1+m+n≦4. These are are LTB4-antagonists. Also disclosed are processes for making these compounds.
摘要翻译:式I中的吡喃糖苷衍生物,其中m和n彼此独立地表示选自0,1,2,3和4以及1 + m + n <= 4的整数。 这些是LTB4拮抗剂。 还公开了制备这些化合物的方法。